Cintas Corporation
—- Market cap
- —
- Debt
- —
- Cash
- −$289.02M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CTAS stock price vs SUM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SUM's multiple
Needs SUM P/E.
Implied fair value · at CTAS's multiple
Needs Annual EPS, CTAS P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Cintas Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Summit Materials, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNIFIRST CORP
CTAS vs UNF
ABM INDUSTRIES INC /DE/
CTAS vs ABM
Aramark
CTAS vs ARMK
W.W. GRAINGER, INC.
CTAS vs GWW
INTUIT INC.
CTAS vs INTU
IRON MOUNTAIN INC
CTAS vs IRM
Vulcan Materials CO
CTAS vs VMC
MARTIN MARIETTA MATERIALS INC
CTAS vs MLM
Arcosa, Inc.
CTAS vs ACA
CRH PUBLIC LTD CO
CTAS vs CRH
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CTAS can sustain its superior margins and 32.4% ROIC, then holding or accumulating CTAS is reasonable despite the premium price, because its profitability and leverage profile are far stronger than SUM’s; if you require valuation support closer to the provided DCF range, patience is warranted.
CTAS trades at a premium quality multiple profile, with a 41.2x P/E, 7.0x P/S, and 25.5x EV/EBITDA, but no SUM valuation multiples are available for SUM to quantify the relative gap directly. The biggest valuation tension is that CTAS sits near the upper half of its historical band while the DCF range is far below the market price, suggesting the stock already discounts strong execution.
Supporting Metrics